|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-10-9
|
|
pubmed:abstractText |
Rapid bone loss occurs from the proximal femur after allogeneic stem cell transplantation (alloSCT). Objective: The objective of the study was to evaluate effects of high-dose pamidronate therapy on bone loss (BMD) after alloSCT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0021-972X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3835-43
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16835281-Adolescent,
pubmed-meshheading:16835281-Adult,
pubmed-meshheading:16835281-Aged,
pubmed-meshheading:16835281-Bone Density,
pubmed-meshheading:16835281-Bone Remodeling,
pubmed-meshheading:16835281-Cyclosporine,
pubmed-meshheading:16835281-Diphosphonates,
pubmed-meshheading:16835281-Female,
pubmed-meshheading:16835281-Glucocorticoids,
pubmed-meshheading:16835281-Humans,
pubmed-meshheading:16835281-Male,
pubmed-meshheading:16835281-Middle Aged,
pubmed-meshheading:16835281-Osteonecrosis,
pubmed-meshheading:16835281-Osteoporosis,
pubmed-meshheading:16835281-Stem Cell Transplantation,
pubmed-meshheading:16835281-Transplantation, Homologous
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Pamidronate reduces bone loss after allogeneic stem cell transplantation.
|
|
pubmed:affiliation |
Department of Medicine, University of Melbourne, Western Hospital, Footscray 3011, Australia.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
